Press Release

Sword Bio Appoints John Moriarity as Vice President, Business Development, East Coast

John Moriarity

Sword Bio (“Sword”), a contract research organization that supports biotech and pharmaceutical companies with their bioanalytical needs for pre-clinical and clinical trials, announces the appointment of John Moriarity VP, Business Development, East Coast.  John brings more than 20 years of biopharma experience to Sword Bio, with a career that began in the laboratory and evolved…

Read More...

Sword Bio Appoints Michael Losauro as Vice President, Business Development, West Coast

Michael Losauro

Sword Bio (“Sword”), a contract research organization that supports biotech and pharmaceutical companies with their bioanalytical needs for pre-clinical and clinical trials, announces the appointment of Michael Losauro VP, Business Development West Coast. Mike joins Sword Bio with more than 20 years of experience driving commercial growth and building strategic partnerships across the biotech and…

Read More...

Sword Bio Expands Space to Support Growth

Sword Bio today announced that it has expanded into additional space to accommodate the rapid growth the company has experienced over the past year. The team has nearly doubled in size, driven by exceptional market response to Sword Bio’s commitment to scientific expertise, personalized service, and industry-leading lead times. With the newly added space, Sword…

Read More...

Sword Bio Appoints Nina Sahay, as Head of Quality Assurance

Sword Bio (“Sword”), a contract research organization that supports biotech and pharmaceutical companies with their bioanalytical needs for pre-clinical and clinical trials, announces the appointment of Nina Sahay as Associate Director of Quality Assurance. Nina Sahay, RQAP-GLP joins Sword Bio as the Associate Director of Quality Assurance and brings with her over 20 years of…

Read More...

Sword Bio Appoints Jim McNally, PhD. as Chief Scientific Officer

Sword Bio (“Sword”), a contract research organization that supports biotech and pharmaceutical companies with their bioanalytical needs for pre-clinical and clinical trials, announces the appointment of Jim McNally as Chief Scientific Officer. Dr. McNally joins Sword with an extensive background in bioanalytical assay development and biotherapeutic program leadership spanning more than 25 years working in…

Read More...

Sword Bio featured member of iBio

iBIO MEMBER FEATURE Sword Bio – From Innovative Technology to Bioanalytical CRO In an exciting new series highlighting the remarkable companies within our Illinois life sciences community, we’re pleased to feature Sword Bio, a success story that emerged from the Illinois Medical District (IMD). In a recent conversation with CEO David Dingott, we learned about…

Read More...

Sword Bio Awarded Most Innovative Collaborative Bioanalytical Lab 2024- USA

Sword Bio Awarded Most Innovative Collaborative Bioanalytical Lab 2024- USA:   

Read More...

Sword Bio Appoints Dr. Binodh DeSilva as a Board Member

Sword Bio (“Sword”), a contract research organization that supports biotech and pharmaceutical companies with their bioanalytical needs for pre-clinical and clinical trials, announces the appointment of Binodh DeSilva to Sword’s board of directors. Dr. Binodh DeSilva is an accomplished senior executive experienced in creating highly innovative global scientific organizations in the pharmaceutical and biotechnology industry….

Read More...

Sword Bio Appoints Seth Reid as Vice President, Business Development

Sword Bio (“Sword”), a contract research organization that supports biotech and pharmaceutical companies with their bioanalytical needs for pre-clinical and clinical trials, announces the appointment of Seth Reid as VP, Business Development.  Seth joins Sword with a proven track record leading and supporting business development programs in the contract research space. Most notably, Sr. Director/Head,…

Read More...

Sword Bio Appoints Kara Harrison as Vice President, Quality Assurance  

Welcome to the team - Kara Harrison

Sword Bio (“Sword”), a contract research organization that supports biotech and pharmaceutical companies with their bioanalytical needs for research, pre-clinical and clinical trials, announces the appointment of Kara Harrison as VP of Quality Assurance.   Kara joins Sword with a proven record of leading and scaling quality management programs and initiatives. Most recently, she was VP,…

Read More...